T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Metallus
MTUS
$902M
| $483K | ﹤0.01% |
53,100
+22,600
| +74% | +$165K |
|
|
NP
1977
DELISTED
Neenah, Inc. Common Stock
NP
| $483K | ﹤0.01% |
7,594
+3,200
| +73% | +$190K |
|
|
RICE
1978
DELISTED
Rice Energy Inc.
RICE
| $482K | ﹤0.01% |
34,495
-5,300
| -13% | -$55.1K |
|
|
CYNO
1979
DELISTED
Cynosure, Inc. Class A
CYNO
| $482K | ﹤0.01% |
10,917
| – | – |
|
1980
FNB Corp
FNB
$6.89B
| $480K | ﹤0.01% |
36,877
+7,071
| +24% | +$88K |
|
1981
Sonida Senior Living
SNDA
$1.89B
| $480K | ﹤0.01% |
1,727
-1,355
| -44% | -$353K |
|
|
MTOR
1982
DELISTED
MERITOR, Inc.
MTOR
| $480K | ﹤0.01% |
59,500
| – | – |
|
1983
KB Home
KBH
$3.44B
| $477K | ﹤0.01% |
33,400
-9,900
| -23% | -$116K |
|
1984
Piper Sandler
PIPR
$5.44B
| $475K | ﹤0.01% |
38,360
-5,600
| -13% | -$56.7K |
|
|
ARIA
1985
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $475K | ﹤0.01% |
74,300
+11,900
| +19% | +$66.7K |
|
1986
BGC Group
BGC
$5.19B
| $472K | ﹤0.01% |
81,016
| – | – |
|
1987
Geron
GERN
$1B
| $472K | ﹤0.01% |
161,700
+71,900
| +80% | +$215K |
|
|
BGC
1988
DELISTED
General Cable Corporation
BGC
| $471K | ﹤0.01% |
38,600
+9,900
| +34% | +$101K |
|
1989
Corcept Therapeutics
CORT
$12.1B
| $470K | ﹤0.01% |
100,454
| – | – |
|
|
IVC
1990
DELISTED
Invacare Corporation
IVC
| $469K | ﹤0.01% |
35,600
+20,000
| +128% | +$284K |
|
|
MDRX
1991
DELISTED
Veradigm Inc. Common Stock
MDRX
| $468K | ﹤0.01% |
35,390
+7,000
| +25% | +$91.9K |
|
|
BRKL
1992
DELISTED
Brookline Bancorp
BRKL
| $467K | ﹤0.01% |
42,399
| – | – |
|
1993
La-Z-Boy
LZB
$1.69B
| $467K | ﹤0.01% |
17,480
| – | – |
|
1994
Independent Bank
INDB
$4.04B
| $465K | ﹤0.01% |
10,120
| – | – |
|
1995
Motorcar Parts of America
MPAA
$236M
| $465K | ﹤0.01% |
12,250
| – | – |
|
|
VRNT
1996
DELISTED
Verint Systems
VRNT
| $463K | ﹤0.01% |
27,207
| – | – |
|
|
BRS
1997
DELISTED
Bristow Group, Inc.
BRS
| $463K | ﹤0.01% |
24,470
-117,320
| -83% | -$2.17M |
|
|
NTRI
1998
DELISTED
NutriSystem, Inc.
NTRI
| $463K | ﹤0.01% |
22,200
+7,100
| +47% | +$140K |
|
1999
AAR Corp
AIR
$5.83B
| $461K | ﹤0.01% |
19,790
+4,400
| +29% | +$95.3K |
|
2000
Lakeland Financial Corp
LKFN
$1.56B
| $460K | ﹤0.01% |
15,060
+3,300
| +28% | +$95.5K |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.